Impact of rotavirus vaccination on seizure hospitalizations in children: A systematic review

Jorge Arasa1, Mónica López-Lacort1, Javier Díez-Domingo2

  • 1Vaccines Research Unit, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, FISABIO-Public Health, Avda. Cataluña, 21, 46020 Valencia, Spain.

Vaccine
|October 24, 2022
PubMed

Insights

Rotavirus (RV) vaccination may reduce hospitalizations for seizures in young children. However, inconsistent study designs and definitions limit definitive conclusions, necessitating further research.

Area of Science:

  • Pediatric infectious diseases
  • Vaccinology
  • Epidemiology

Background:

  • Conflicting evidence exists regarding the impact of rotavirus (RV) vaccination on seizure hospitalizations in children under five.
  • Understanding this association is crucial for public health recommendations and pediatric care.

Approach:

  • A systematic review of observational studies published since 2006 was performed.
  • Studies were identified through MEDLINE, with rigorous title/abstract, full-text review, and data extraction by two independent reviewers.

Key Points:

  • Thirteen studies met the inclusion criteria for the review.
  • Nine studies indicated a significant decrease in seizure hospitalizations following RV vaccine introduction.
  • Three studies found no significant impact, while one reported a rise in hospitalizations.

Conclusions:

  • Variability in study methodologies, case definitions, and potential biases hinder the quantification of RV vaccination's effect on seizure hospitalizations.
  • While RV vaccination shows potential for preventing seizure hospitalizations, more robust, well-designed studies are required to establish a definitive link.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
45.2K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
411
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
246
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
543
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.3K
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
936